Sodium Hyaluronate Pharma Grade


Sodium Hyaluronate Pharma Grade is a highly purified and well-characterized sodium hyaluronate developed for use in biomedical and pharmaceutical applications. Sodium Hyaluronate Pharma Grade is produced by NovaMatrix® strategic partner, Kikkoman Biochemifa Company (KBC), Japan . The fermentation of ultra pure sodium hyaluronate is based on more than 10 years of experience and the plant is constructed and run in compliance with cGMP guidelines for bulk pharmaceuticals. The ultra pure sodium hyaluronates from Kibun is described in a DMF submitted to the US FDA. In addition to sodium hyaluronate, NovaMatrix also provides ultra pure alginate and chitosan, poly-anionic and poly-cationic polymers, respectively, that can be used in combination with hyaluronan.

Sodium Hyaluronate, fermented from Streptococcus zooepidemicus, is a linear copolymer composed of (ß-1,4)-linked D-glucuronate and (ß-1,3)-N-acetyl-D-glucosamine. Sodium Hyaluronate is an abundant glycosaminoglycan found in the extracellular matrix of skin, joints, eyes and most organs and tissues of all higher animals. It is the only non-sulfated glycosaminoglycan and forms highly viscous aqueous solutions.